Image preview

Sara C. Keller, MD, MPH, MSHP
SRN Chair

Dr. Keller is an Assistant Professor of Medicine in the Division of Infectious Disease at Johns Hopkins University School of Medicine. She is also Director of the Johns Hopkins University Osler Medical Residency Training Program Patient Safety and Quality Improvement Pathway.

Dr. Keller's research interests focus on improving the quality of care of patients receiving parenteral antibiotics outside the hospital, measures, and outcomes among patients with central venous catheters in the home, and improving ambulatory antimicrobial stewardship.

Dr. Keller received her undergraduate degree from the University of Maryland, her masters of public health degree in epidemiology at the University of North Carolina, her medical degree from Duke University School of Medicine, and her masters of science in health policy research degree from the University of Pennsylvania Perelman School of Medicine. She completed her postgraduate training in internal medicine at the Johns Hopkins School of Medicine. She underwent subsequent training in infectious diseases and in the Centers for Healthcare Improvement and Patient Safety at the University of Pennsylvania Perelman School of Medicine.

female silhouette icon

Kathleen Chiotos, MD, MSCE
SRN Vice Chair

Dr. Chiotos is a core faculty member of the Pediatric Infectious Diseases Epidemiology and Antimicrobial Stewardship (IDEAS) research group at the Center for Pediatric Clinical Effectiveness (CPCE), an attending physician in the pediatric intensive care unit (PICU) at The Children’s Hospital of Philadelphia (CHOP), and Assistant Professor of Anesthesiology and Critical Care at the Perelman School of Medicine at the University of Pennsylvania with a secondary appointment in pediatric infectious diseases. She was formerly a Fellow in the Pediatric Hospital Epidemiology and Outcomes Research Training (PHEOT) program managed by the CPCE. She completed a combined fellowship in Pediatric Infectious Diseases and Critical Care Medicine at CHOP and received a Master of Science in Clinical Epidemiology from the University of Pennsylvania. Her research interests are related to the epidemiology and treatment of multidrug resistant gram-negative infections as well as antimicrobial stewardship in the PICU setting.

SRN Past Chairs

  • Marin Schweizer, SRN Review Committee Chair 2017-2020
  • Clare Rock, SRN Chair 2019-2020; SRN Vice Chair 2017-2019
  • Jennifer Han, SRN Chair 2017-2019
  • Daniel Morgan, SRN Chair 2012-2017
  • Aaron Milstone, SRN Review Committee Chair 2012-2017
  • Deverick Anderson, SRN Vice Chair 2014-2017
  • Anthony Harris, SRN Chair 2010-2014
  • David Henderson, SRN Founding Chair 2010



The healthcare facilities that make up the SHEA Research Network (SRN) respond to 5-10 research projects every year. These projects are reviewed and approved by the SRN Review Committee for their potential contributions to the knowledge base of healthcare epidemiology. 

SRN Elite institutions have the highest response rate and are recognized for their exemplary contributions to the SRN. SHEA is grateful to all the SRN participating facilities.

SRN Demographics: 2021-2022

  • 95 unique healthcare facilities
  • 19 countries and 35 states
  • 87 with Infection Control Programs
  • 79 with Antimicrobial Stewardship Programs 
  • 58 with IRBs
  • 5: median ICUs
  • 430: median adult beds
  • 100: median pediatric beds
  • 1.5: average number of hospital epidemiologists 
  • 5.5: average number of infection preventionists

Elite, North America (43)

  • Baltimore VA Medical Center
  • Baystate Medical Center
  • Boston Children's Hospital
  • Boston Medical Center
  • Children's Hospital Colorado
  • Children's Hospital of San Antonio
  • Children's National Medical Center
  • Christiana Care Health System
  • Cincinnati Children's Hospital Medical Center
  • Dartmouth-Hitchcock Medical Center
  • Duke University Hospital
  • Froedtert West Bend Hospital
  • Hamilton Health Sciences
  • Hospital of the University of Pennsylvania
  • Intermountain Medical Center
  • IU Health Goshen
  • Kaweah Delta Medical Center
  • Loyola University Medical Center
  • Maine Medical Center
  • Mayo Clinic Hospital
  • Memorial Hermann Texas Medical Center
  • Miami Valley Hospital
  • Michigan Medicine
  • Mount Sinai Hospital
  • New York-Presbyterian/Weill Cornell Medical Center
  • NIH Clinical Center
  • Provincial Health Services Authority
  • Saint Luke's North Hospital
  • San Francisco General Hospital
  • Stamford Health
  • The Johns Hopkins Hospital
  • The Joint Commission
  • University of Arizona College of Medicine
  • University of Chicago Medicine Comer Children's Hospital
  • University of Connecticut Health Center
  • University of Nebraska Medical Center
  • University of New Mexico Hospitals
  • University of North Carolina at Chapel Hill
  • University of Wisconsin Hospital
  • VA Portland Health Care System
  • Vidant Medical Center
  • WakeMed Health & Hospitals
  • William S. Middleton VA Hospital

Active, North America (36)

  • AdventHealth Ocala
  • Advocate Christ Medical Center
  • Banner University Medical Center Phoenix
  • Bethesda North Hospital
  • Brigham and Women's Hospital
  • Centre Hospitalier Pierre-Legardeur
  • Children's Hospital of Philadelphia
  • Emory University - Grady Memorial Hospital
  • Emory University Hospital Midtown
  • Eskenazi Health
  • Geisinger Medical Center
  • Iowa City VA Medical Center
  • Jackson Health System
  • Keck Medicine of University of Southern California
  • Mayo Clinic Florida
  • Mayo Clinic, Rochester
  • Nationwide Children's Hospital
  • New York University
  • Oregon Health and Science University
  • Parkview Health
  • Pomona Valley Hospital Medical Center
  • Rhode Island Hospital
  • Seattle Children's Hospital
  • UMass Memorial Medical Center
  • University of Alabama at Birmingham
  • University of California Irvine Health
  • University of Illinois Hospital & Health Sciences
  • University of Kentucky
  • University of Maryland Medical Center
  • University of Utah Health
  • University of Vermont Medical Center
  • UT Southwestern Medical Center
  • Wake Forest Baptist Health
  • Washington University/Barnes-Jewish Hospital
  • Yale New Haven Hospital

Elite, International (6)

  • An Najah National University Hospital
  • Dar Al Fouad
  • Hospital Universitario de Badajoz
  • Seoul National University Bundang Hospital
  • St. John's National Academy of Health Sciences
  • University of Navarra Clinic

Active, International (10)

  • Bhailal Amin General Hospital
  • BLK Super Specialty Hospital
  • Breach Candy Hospital Trust
  • Chacha Nehru Bal Chikitsalaya
  • Instituto Nacional de Cancerologia
  • Jagiellonian University Collegium Medicum
  • Pranaam Hospitals
  • Santa Casa de Misericardia de Resende
  • Western Health





 Join the SHEA Research Network, submit a research project proposal -- learn more.

Epi Project and Research Scholar Awards 

Year Title Principal Investigator

Epi Project

Diagnostic Stewardship of Multiplex Molecular Panel Tests to Improve Antibiotic Use Jonathan Baghdadi
Research Scholar Award
Burnout in Antimicrobial Stewardship: A Mixed Methods Study Julia Szymczak
Research Scholar Award
Development of Validated Diagnostic Stewardship Strategy to Improve Reflex Urine Culture Utilization and Diagnosis of Urinary Tract Infections Sonali Advani
Epi Project
Molecular Epidemiology of Spinal Fusion Surgical Site Infection and Influence of Preoperative Patient Microbiome Dustin Long
Epi Project
Antibiotic Overuse at Hospital Discharge Valerie Vaughn
Research Scholar Award
A Diagnostic Stewardship Intervention to Improve Blood Culture Use among Adult Nonneutropenic Inpatients: The Distribute Study
Valeria Fabre, Eili Klein, Alejandra B. Salinas, George Jones, Karen C. Carroll, Aaron M. Milstone, Joe Amoah, Yea-Jen Hsu, Avinash Gadala, Sanjay Desai, Amit Goyal, David Furfaro, Jacquelyn Zimmerman, Susan Lin, Sara E. Cosgrove. Journal of Clinical Microbiology Sep 2020.
Valerie Fabre
Epi Project

Roles and role ambiguity in patient and caregiver-performed outpatient parenteral antimicrobial therapy
Keller SC, Cosgrove SE, Arbaje AI, Chang RH, Krosche A, Williams D, Gurses AP. Jt Comm J Qual Pt Safety. 2019;45:763-771.

Hazards from physical attributes of the home environment among patients on outpatient parenteral antimicrobial therapy (OPAT)
Keller SC, Cosgrove SE, Kohut M, Krosche A, Chang RH, Williams D, Gurses AP. Am J Infect Control. 2019;47:425-430.

It's complicated: patient and informal caregiver performance of outpatient parenteral antimicrobial therapy-related tasks
Keller SC, Cosgrove SE, Arbaje AI, Chang RH, Krosche A, Williams D, Gurses AP. Am J Med Qual. 2020;35:133-146.

Sara Keller
Epi Project
Variation in Practices to Clean and Disinfect Surfaces in SHEA Research Network Facilities  Sujan Reddy
Epi Project
Applying the Washington State Validation Protocol to Central Line-Associated Bloodstream Infection (CLABSI) Reporting Across a National Cohort  Jason Lempp
Epi Project
A Multicenter Longitudinal Study of Hospital-Onset Bacteremia: Time for a New Quality Outcome Measure?Rock C, Thom KA, Harris AD, Li S, Morgan D, Milstone AM, Caffo B, Joshi M, Leekha S.Infect Control Hosp Epidemiol. 2016 Feb; 37:143-8. Clare Rock
Epi Project
Variation in Definitions and Isolation Procedures for Multidrug-Resistant Gram-Negative Bacteria: A Survey of the Society of Healthcare Epidemiology of America Research Network
Drees M, Pineles L, Harris A, Morgan D. Infect Control Hosp Epidemiol. 2014 Apr; 35: 362-6.

Marci Drees

SRN Projects


  1. Upcoming: State of the SRN and SHEA Research Priorities; Burnout in Hospital Epidemiology and Antibiotic Stewardship; Disparities in HAI Prevention
  2. Current Use of Routine Contact Precautions for MDROs, PI: Emily Martin
  3. Curtailing Nosocomial Amplification of COVID-19 with Mathematical Modeling, PI: Eric Lofgren
  4. Efforts to Prevent Non-Ventilator Hospital-Acquired Pneumonia, PIs: Dian Baker, Karen Giuliano
  5. HVAC Settings, SSIs, COVID-19, and Climate Change, PI: Jason Burnham
  6. Peri-Operative Antibiotics in Neurosurgery, PI: Rahul Sastry


  1. Diagnostic and antimicrobial stewardship with molecular respiratory testing across the SHEA Research Network. Claeys KC, Morgan DJ, Leekha S, Sullivan KV. Infect Control Hosp Epidemiol. Dec 2020;3:1-4.
  2. Surveillance practices and air-sampling strategies to address healthcare-associated invasive mold infections in SHEA Research Network hospitals—United States, 2020. Gold JAW, Jackson BR, Glowicz J, Mead KR, Beer KD. Infect Control Hosp Epidemiol. 2021:1–4.
  3. Policies and practices of SHEA Research Network hospitals during the COVID-19 pandemic. Calderwood MS, Deloney VM, Anderson DJ, Cheng VC-C, Gohil S, Kwon JH, Mody L, Monsees E, Vaughn VM, Wiemken TL, Ziegler MJ, Lofgren E. Infect Control Hosp Epidemiol. 2020;41:1127–1135.
  4. Use of diagnostic and antimicrobial stewardship practices to improve Clostridioides difficile testing among SHEA Research Network hospitals. Sullivan KV, Gallagher JC, Leekha S, Morgan DJ, Morita K, Rock C, Claeys KC. Infect Control Hosp Epidemiol. Mar 2021:1–5.
  5. Study of Effect of Fluoroquinolone Restriction on CDI (FIRST Trial), PI: Nasia Safdar
  6. How are Emerging Data Translated into Clinical Practice? A Mixed Methods Investigation of COVID-19 Institutional Treatment Protocols. Asundi A, Resnik J, Benedict P, Shin M, Elwy RA, and Branch-Elliman, W. Open Forum Infectious Diseases, 2021. 
  7. PPE-SAFE contributors. Personal protective equipment and intensive care unit healthcare worker safety in the COVID-19 era (PPE-SAFE): An international survey, Tabah A, Ramanan M, Laupland KB, Buetti N, Cortegiani A, et al; J Crit Care. Oct 2020;59:70-75. 
  8. Active Bathing to Eliminate Infection (ABATE), PI: Jonathan Zenilman
  9. The Value and Impact of Public Reporting, PI: Gregory Schrank
  10. Sepsis Research Priorities, PI: Nasia Safdar 


  1. Implementation of infectious diseases rapid molecular diagnostic tests and antimicrobial stewardship program involvement in acute-care hospitals. Kondo M, Simon MS, Westblade LF, Jenkins SG, Babady NE, Loo AS, Calfee DP; SHEA Research Network. Infect Control Hosp Epidemiol. Oct 2020;16:1-3.
  2. Infection Prevention Training for Frontline Personnel (Prevention CHKC) Needs Assessment, SHEA Prevention Course for HAI Knowledge and Control of HAIs (Prevention CHKC) Program Committee
  3. Prolonged postprocedural antimicrobial use: A survey of the Society for Healthcare Epidemiology of America Research Network. Puig-Asensio M, Perencevich EN, Livorsi DJ. Infect Control Hosp Epidemiol. Nov 2019;40:1281-1283.
  4. Practice Variation in Validation of Device Denominator Data for National Healthcare Safety Network Reporting. Challener D, Sampathkumar P, O’Horo J. Infect Control Hosp Epidemiol. 2020;41:S354-S355.
  5. Perspectives on antimicrobial use at the end of life among antibiotic stewardship programs: A survey of the Society for Healthcare Epidemiology of America Research Network. Datta R, Topal J, McManus D, Dembry L, Quagliarello V, Juthani-Mehta M. Infect Control Hosp Epidemiol. 1-3.
  6. Perceptions of Data Management in Infection Prevention, PI: Carlos Figueroa-Castro
  7. Perspectives on central-line associated bloodstream infection surveillance in home infusion therapy. Keller S, Alexander M, Williams D, Rock C, Han J, Schweizer M, Gorski L. Infect Control Hosp Epidemiol. 2019;40:729-31. 
  8. Assessing the composition and function of existing antimicrobial stewardship committees in the practice-based setting as compared to published guidelines, PI: Matthew Weissenbach
  9. Variability in antifungal stewardship strategies among Society for Healthcare Epidemiology of America (SHEA) Research Network facilities. Fitzpatrick MA, Albarillo F, Santarossa M, Evans CT, Suda KJ. Infect Control Hosp Epidemiol. May 2020;41:585-589. 
  10. Current infection prevention and antibiotic stewardship program practices: A survey of the Society for Healthcare Epidemiology of America (SHEA) Research Network (SRN) Chiotos K, Rock C, Schweizer M, Han J et al. Infect Control Hosp Epidemiol. Jul 2019;17:1-4. 


  1. Status of the prevention of multidrug-resistant organisms in international settings: a survey of the Society for Healthcare Epidemiology of America Research Network. Safdar N, Sengupta S, Musuuza JS.  Infect Control Hosp Epidemiol. 2017;38:53-60
  2. Hospital epidemiologists’ and infection preventionists’ opinions regarding hospital-onset bacteremia and fungemia as a potential healthcare-associated infection metric. Dantes R, Abbo L, Anderson D, Hall L, Han J, Harris A, Rock C, et al. Infect Control Hosp Epidemiol. 2019;40:536-40. 
  3. Use of diagnostic stewardship practices to improve urine culturing among SHEA Research Network hospitals. Sullivan KV, Morgan DJ, Leekha S. Infect Control Hosp Epidemiol. 2019 Feb;40:228-231.
  4. Variability in the Application of Surveillance Definitions for Central Line-Associated Bloodstream Infection across U.S. Hospitals, PIs: Adams Barker C, Calderwood M, Dowling-Schmitt M. IDWeek 2018.
  5. Visitor screening and staff sick leave policies in US hospitals. Chow E, Smit M, Mermel L. Infect Control Hosp Epidemiol. 2018;39:1006-8. 
  6. Preventing hospital-acquired Legionnaires’ disease: A snapshot of clinical practices and water management approaches in US acute-care hospitals. Ehret K, Chamberlain A, Berkelman R, Fridkin, S. Infect Control Hosp Epidemiol. 2018;39: 1470-2. 


  1. Interfacility transfer communication of multidrug-resistant organism colonization or infection status: Practices and barriers in the acute-care setting. Ellingson KD, Noble BN, Buser GL, Snyder GM, McGregor JC, Rock C, Chopra T, Mody L, Furuno JP. Infect Control Hosp Epidemiol. 2021;1–6.
  2. Do Experts Understand Performance Measures? A Mixed-Methods Study of Infection Preventionists. Govindan S, Wallace B, Iwashyna TJ, Chopra V. Infect Control Hosp Epidemiol. Jan 2018;39:71-6. 
  3. Infection prevention in the operating room anesthesia work area. Munoz-Price L, Bowdle A, Johnston B, Bearman G, Camins B, Dellinger E, Birnbach D et al. Infect Control Hosp Epidemiol. 2019;40, 1-17.
  4. Choosing Wisely in Healthcare Epidemiology and Antimicrobial Stewardship. Morgan DJ, Croft LD, Deloney V, et al. Infection Control & Hospital Epidemiology. 2016;37:755-760.
  5. Duration of Contact Precautions for Acute-Care Settings. Banach DB, Bearman G, Barnden M, et al. Infect Control Hosp Epidemiol. 2018;39:127-44.
  6. Outbreak Response and Incident Management: SHEA Guidance and Resources for Healthcare Epidemiologists in United States Acute-Care Hospitals. Banach DB, Johnston BL, Al-Zubeidi D, et al. Infect Control Hosp Epidemiol. 2017;38:1393-419.
  7. Implementation of Infection Prevention and Antimicrobial Stewardship in Cardiac Electrophysiology Laboratories: Results from the SHEA Research Network. Mehrotra P, Gupta K, Strymish J, Branch-Elliman, W. et al. Infect Control Hosp Epidemiol. 2017;38:496-8. 
  8. Survey on the Activities of the World Health Organization (WHO) against Antimicrobial Resistance, PI: Ida Marie Nyhagen Vikan 
  9. Legal Implications of Antimicrobial Stewardship. Maliha G, Nepps ME, Tamma PD, Dodds Ashley E, Szymczak JE, Kolesar E, Hamilton KW. Infect Control Hosp Epidemiol. May 2020;13:1-8.
  10. NOSOFlu: Developing Healthcare-Associated Flu Definitions, PI: Philippe Vanhems


  1. Audit and Feedback Processes Among Antimicrobial Stewardship Programs: A Survey of the Society for Healthcare Epidemiology of America Research Network. Livorsi D, Heintz B, Jacob J, Krein S, Morgan D, Perencevich E. Infect Control Hosp Epidemiol. 2016;37:704-6.
  2. Variation in Definitions and Isolation Procedures for Multidrug-Resistant Gram-Negative Bacteria: A Survey of the Society for Healthcare Epidemiology of America Research Network. Drees M, Pineles L, Harris AD, Morgan DJ. Infect Control Hosp Epidemiol. May 2016;35:362–366.
  3. ERCP Endoscope Reprocessing Practices to Reduce the Risk of CRE Transmission, PI: David Yassa
  4. The Expanding Role of the Hospital Epidemiologist in 2014: A Survey of the Society for Hospital Epidemiology of America (SHEA) Research Network. Morgan D, Deloney V, Bartlett A, Boruchoff S, Couto R, Oji M, Poojary A, Rogers G, Sulis C, Milstone A. Infect Control Hosp Epidemiol. May 2016;36:605-8.


  1. How to Study Quality Improvement Strategies, PI: Susan Huang
  2. Lessons Learned from Hospital Ebola Preparation. Morgan D, Braun B, Milstone A, Anderson D, Harris A, et al. Infect Control Hosp Epidemiol. 36:627-631. 
  3. Reconsidering Contact Precautions for Endemic MRSA and VRE. Morgan D, Murthy R, Munoz-Price L, Barnden M, Camins B, Johnston B, Bearman G. Infect Control Hosp Epidemiol. 36:1163-1172. 
  4. Animals in Healthcare Facilities: Recommendations to Minimize Potential Risks. Murthy R, Bearman G, Brown S, Bryant K, Chinn R, Hewlett A, George BG, Goldstein E, Holzmann-Pazgal G, Rupp M, Wiemken T, Weese JS, Weber D. Infect Control Hosp Epidemiol. 2015.


  1. Survey of Hospital Practices Regarding Use of Chlorhexidine Gluconate Bathing for Prevention of Healthcare-Associated Infections. Shuman, E, Harpe J, Calfee D; IDWeek 2014.
  2. Survey of infection prevention informatics use and practitioner satisfaction in US hospitals. Masnick M, Morgan DJ, Wright MO, Lin MY, Pineles L, Harris AD. Infect Control Hosp Epidemiol. Jul 2014;35:891-3. 
  3. SHEA Expert Guidance on Healthcare Personnel Attire in Non-Operating-Room Settings. Bearman G, Bryant K, Leekha S, Mayer J, Munoz-Price LS, Murthy R, Palmore T, Rupp M, White J. Infect Control Hosp Epidemiol. Feb 2014;35:107-21.


  1. Universal Glove and Gown Use and Acquisition of Antibiotic-Resistant Bacteria in the ICUA: Randomized Trial. Harris A, Pineles L, Belton B, Johnson K, Shardell M, Loeb M, Newhouse R, Dembry L, Braun B, Perencevich E, Hall K, Morgan D, Benefits of Universal Glove and Gown (BUGG) Investigators. JAMA. 2013;310:1571-80. 
  2. Public Reporting of Hospital Acquired Infections is Not Associated with Improved Processes or Outcomes. Linkin D, Fishman N, Shea J, Yang W, Cary M, Lautenbach E. Infect Control Hosp Epidemiol. 34:844-846. Survey
  3. Pediatric Antimicrobial Susceptibility Trends across the United States. Tamma P, Robinson G, Gerber J, Newland J, DeLisle C, Zaoutis T, Milstone A. Infect Control Hosp Epidemiol. Dec 2013;34,1244-51.
  4. Does Nonpayment for Hospital-Acquired Catheter-Associated UTIs Lead to Overtesting and Increased Antimicrobial Prescribing? Morgan DJ, Meddings J, Saint S, Lautenbach E, Shardell M, Anderson D, Milstone AM, Drees M, Pineles L, Safdar N, Bowling J, Henderson D, Yokoe D, Harris AD. Clin Infect Dis. Oct 2012;55:923-9. 
  5. Surveillance of Healthcare-Associated Infections. Keller SC, Linkin DR, Fishman NO, Lautenbach E. Infect Control Hosp Epidemiol. Jul 2013;34:678-86. 
  6. Variable Screening and Decolonization Protocols for Staphylococcus aureus Carriage before Surgery. Kline S, Pham T, Perl T; IDWeek 2012.

The SHEA Research Network (SRN) is a consortium of over 100 unique healthcare facilities collaborating on multicenter research projects in healthcare epidemiology and antimicrobial stewardship. 

All healthcare facilities with a dedicated site PI are able to join the SRN and participate in projects. View previous SRN projects here.

Engaging the Network

Approval of proposed research projects is determined by the SRN Review Committee following submission of a proposal concept application to

Proposals funded by an external source or those seeking funding from an external source will be reviewed for project significance and alignment with SHEA's mission and the capabilities of the SRN. For unfunded proposals, is given to the burden on participating sites. Review of a proposal will not commence until all materials are received.

Join the SRN

Submit a Proposal

Apply for a Letter of Support

SRN Studies SRN Members SRN Leadership Team

Fee Structure

  • Government or NGO-funded projects (excluding training or career development grants): $2,000
  • Corporate-funded projects: $5,000
  • No fees apply to unfunded research projects (i.e. conducted with no visible means of support). If approved, unfunded projects are supported by the SHEA Education and Research Foundation

Fees cover review and solicitation of members, but not administrative support, data management, or projects beyond normal scope (e.g. Delphi process with multiple rounds of surveying). Projects are invoiced after SHEA review and acceptance.

High-Priority Topics (1, 2)

COVID-19 (1)
  • Transmission dynamics of SARS-CoV-2, including asymptomatic spread
  • Risk factors for severe disease and COVID-19 sequelae
  • Interventions to stop COVID-19 outbreaks, including surveillance, outbreak investigation, isolation precautions, testing, environmental cleaning, source control, and use of PPE
  • Socio-behavioral, contextual, and cultural factors
  • Impact on antibiotic prescribing
  • HAI prevention in non-acute care settings
  • Implementation of HAI prevention methods
  • Technology to manage hand hygiene compliance
Device-associated infections (including CLABSI, CAUTI, VAE)
  • Epidemiology of device-associated infections in non-ICU settings
  • Novel technology for device-associated infection prevention
  • Reliability and validity of surveillance definitions in different patient populations and their impact on outcomes and practices
  • Postoperative wound care strategies
  • Impact of an operating room checklist 
  • Patient-specific risk factor modification
MDROs and C. difficile
  • Transmission dynamics
  • Novel interventions for acute and non-acute care settings
  • Role of the environment and the impact of environmental disinfection on transmission
  • Role of laboratory technology 
Employee health
  • Methods to improve uptake of vaccinations in healthcare personnel (HCP) in settings where mandatory vaccination is not feasible
  • Prevention of needlestick injuries and other bloodborne pathogen exposures in HCP
  • Methods for post-exposure prophylaxis for prevention of HIV, HCV, and HBV
  • Role of HCP in transmitting organisms to patients
Respiratory viruses
  • Effects of barrier precautions on respiratory virus transmission
  • PPE for prevention of respiratory virus transmission
  • Novel diagnostics
Antimicrobial stewardship
  • Impact of antimicrobial stewardship programs on emergence of resistance, patient outcomes, and cost
  • Alternative methods for antimicrobial stewardship such as post-prescription review
  • Performance metrics for antimicrobial stewardship
  • Efficacy of touchless cleaning technologies 
  • Surveillance of environmental cleaning
  • Role of hospital epidemiologists and infection preventionists in changing policy related to environmental cleaning

(1) COVID-19 Research Agenda for Healthcare Epidemiology. Mody L, Akinboyo IC, Babcock HM, Bischoff WE, Cheng VC-C, Chiotos K, Claeys KC, Coffey KC, Diekema DJ, Donskey CJ, Ellingson KD, Gilmartin HM, Gohil SK, Harris AD, Keller SC, Klein EY, Krein SL, Kwon JH, Lauring AS, Livorsi DJ, Lofgren ET, Merrill K, Milstone A, Monsees EA, Morgan DJ, Perri LP, Pfeiffer CD, Rock C, Saint S, Sickbert-Bennett E, Skelton F, Suda KJ, Talbot TR, Vaughn VM, Weber DJ, Wiemken TL, Yassin MH, Ziegler MJ, Anderson DJ. Infect Control Hosp Epidemiol. 2021 Jan. 1-81. 

(2) The evolving landscape of healthcare-associated infections: recent advances in prevention and a road map for research. Safdar N, Anderson DJ, Braun BI, Carling P, Cohen S, Donskey C, Drees M, Harris A, Henderson DK, Huang SS, Juthani-Mehta M, Lautenbach E, Linkin DR, Meddings J, Miller LG, Milstone A, Morgan D, Sengupta S, Varman M, Yokoe D, Zerr DM; Research Committee of the Society for Healthcare Epidemiology of America. Infect Control Hosp Epidemiol. 2014 May;35:480-93.